Fineotex says Rs 3,000 crore FY28 revenue target may slip
Key highlights
- Fineotex said its Rs 3,000 crore revenue ambition could move from FY28 to FY29 or later.
- Management cited an approximately Rs 1,600 crore run rate based on the last 2 quarters.
- Fineotex said 44% of CrudeChem products are sustainable.
- Management said some CrudeChem products generated customer savings of about 17% to 18% in fracking and completion.
powered by IRIS

Fineotex Chemical Limited said its Rs 3,000 crore revenue ambition may not be reached in FY28, with management allowing for FY29 or a later period despite citing an approximately Rs 1,600 crore run rate from the last two quarters. Management linked the timetable to organic growth, chemical-plant opportunities and external conditions.
Know Fineotex Chemical inside out
Results, valuation, peers and who's buying, in one view.
Is Fineotex still targeting Rs 3,000 crore of revenue?
Fineotex is still pursuing Rs 3,000 crore of revenue, but management no longer presented FY28 as a fixed deadline. Asked whether the company was on track for the previously stated FY28 goal, Managing Director Sanjay Tibrewala said Fineotex was examining organic opportunities and opportunities involving chemical plants. He added that if Rs 3,000 crore did not happen in FY28, FY29 or another later period, the company would still be building ahead in its businesses.
Management cited an approximately Rs 1,600 crore run rate after analysing the last two quarters. It said the business could potentially double over the next two, three or four years, but described this as its plan and view rather than a revised financial target. Fineotex did not provide quarterly revenue figures behind the run rate, a revised deadline or a bridge showing how it would reach Rs 3,000 crore.
The Rs 3,000 crore ambition is nearly twice the approximately Rs 1,600 crore run rate cited from the last two quarters. Management’s comments therefore retain the revenue objective while qualifying its timing. The call did not establish how much of future growth would come from Fineotex’s existing operations, CrudeChem or an acquisition.
Why could Fineotex's Rs 3,000 crore target move beyond FY28?
Fineotex said external events could affect the timing of its Rs 3,000 crore goal. Tibrewala cited geopolitical developments, elections and crude-oil price movements, saying the company’s outlook assumed conditions remained broadly constant and favourable. He said the business could still double over two, three or four years, but did not make that outcome a formal forecast.
CrudeChem’s operating conditions illustrate the variability management described. Fineotex said rig counts, geopolitics, freight costs and weather can affect oilfield activity, rather than creating a predictable first-half or second-half pattern. Management said activity can slow from 15 December around Christmas, but that the combined December and January total is generally similar, shifting activity between periods rather than necessarily changing the longer-term opportunity.
Fineotex said it had transferred product technology to CrudeChem to serve United States demand locally, avoiding freight and inventory-control issues associated with exports from India. It also said CrudeChem had begun supplying major Canadian service operators. Management reported that 44% of CrudeChem products are sustainable and said some products had generated customer cost savings of about 17% to 18% in fracking and completion applications.
What is CrudeChem's role in Fineotex's growth plan?
CrudeChem is part of Fineotex’s growth plan, but the company did not quantify its contribution to the Rs 3,000 crore revenue ambition. Management said CrudeChem was performing as expected or slightly better in the quarter under discussion. It also said the business had a plan for calendar year 2028, or CY28, and believed recent growth supported that plan.
Fineotex previously referred to a CY28 target of about $200 million in revenue for CrudeChem, but management did not restate a rupee equivalent or provide an updated financial forecast on this call. Tibrewala said CrudeChem had doubled its business in six to nine months, depending on the measurement point, and suggested this supported the possibility of further expansion over the next six or seven quarters.
The company’s comments also distinguished CrudeChem’s calendar-year planning from Fineotex’s FY28 revenue ambition. Fineotex said United States oilfield activity could grow alongside developments in Guyana and Suriname, while CrudeChem had also started supplies in Canada. These are management’s commercial observations, not disclosed revenue commitments or orders.
Got a follow-up? Ask IRIS
How could Fineotex fund an acquisition?
Fineotex said an acquisition could be funded with cash, debt, equity or a combination, depending on the opportunity, its timing and the urgency of funding. Tibrewala said equity dilution was neither categorically excluded nor predetermined. He said Fineotex could use debt initially and later bridge it through an equity fundraise or another funding route if circumstances required.
Management said any acquisition would be earnings before interest, tax, depreciation and amortisation, or EBITDA, accretive. It also said it was disciplined in deploying cash and was not comfortable adding too much debt, referring to 60 quarters as a listed company without excessive debt or leverage. Fineotex did not disclose a debt limit, cash balance, borrowing capacity or the size of a potential transaction.
Fineotex said acquisitions in the United States could be undertaken through two newly incorporated subsidiaries, while transactions in the Middle East or elsewhere could be made through its wholly owned subsidiaries. Management said the two new subsidiaries had been established less than two months earlier. It did not identify an acquisition target, valuation, geography of a specific deal or timetable.
What operating milestones did Fineotex disclose?
Fineotex said AquaStrike Premium could begin shaping up during the current financial year after regulatory and plant-related progress. Management said its plant had been audited by CIB, that the registration certification showed a September date, and that plant approval had been completed after product registration in Delhi CIB about one year earlier. It did not disclose commercial sales, production volumes or revenue from AquaStrike Premium.
Management also referred to Haffkine approval documentation concerning product performance. Fineotex said a dedicated group of people was focused on generating business for AquaStrike Premium, but did not quantify the team, expected orders or revenue potential. The product is therefore an operational milestone disclosed alongside, rather than a quantified component of, the Rs 3,000 crore revenue pathway.
Conclusion
Fineotex has retained its Rs 3,000 crore revenue ambition while explicitly accepting that FY28 may not be the delivery date. The approximately Rs 1,600 crore run rate from the last two quarters, CrudeChem’s local United States supply model and chemical-plant opportunities form the basis of management’s expansion case. However, oilfield activity, freight costs, rig counts, crude prices and geopolitical events can alter the pace.
The next disclosures to watch are a revised timetable for the Rs 3,000 crore objective, any identified acquisition and its funding structure, and progress against CrudeChem’s CY28 plan. Management also expects AquaStrike Premium to shape up in the current financial year after the September-linked certification and plant approval steps, making commercial activity in that product another stated milestone.


